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Abstract
Objective: Sleep disturbance is highly prevalent among
veterans. As an alternative to sleep medications with their
undesirable side effects, nonpharmacological mind–body inter-
ventions may be beneficial for sleep management in primary care.
The aim of this pilot study was to investigate whether a novel
mind–body intervention, mind–body bridging (MBB), focusing on
sleep, could improve self-reported sleep disturbance and comorbid
symptoms in veterans. Methods: This pilot study was a
randomized controlled trial at the Veterans Affairs Salt Lake City
Health Care System in which 63 veterans with self-reported sleep
disturbance received MBB or an active sleep education control.
Both interventions were conducted in two sessions, once per week.
Patient-reported outcomes included the following: primary—
Medical Outcomes Study (MOS) Sleep Survey, MOS Short
Form-36V; secondary—Center for Epidemiological Studies–
Depression, PTSD Check List–Military, Five-Factor Mindfulness
Questionnaire. Results: At both Week 1 (1 week after the first
session) and post-intervention assessments, while sleep disturbance
decreased in both groups, MBB performed significantly better than
did the control group. Furthermore, self-reported PTSD symptoms
improved in MBB, while they remained unchanged in the control.
Overall mindfulness increased in MBB, while it remained
unchanged in the control. Conclusions: This study provides
preliminary evidence that a brief sleep-focused MBB could be a
promising intervention for sleep and potentially other comorbid
symptoms (e.g., PTSD). MBB could help patients develop
awareness skills to deal with sleep-related symptoms. Integration
of MBB into primary care settings may enhance care of patients
with sleep disturbance and co-morbid symptoms.
© 2011 Elsevier Inc. All rights reserved.
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Introduction
Sleep disturbance and lack of adequate sleep are a
major health concern in both the civilian [1] and military
populations [2]. In currently deployed and post-deployed
military personnel, sleep disturbance may be as high as
74–90% [3,4]. Perpetuating sleep problems in veterans
may lead to reduced quality of life (QOL) and well-being,
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and may contribute to worsening of both mental (e.g.,
post-traumatic stress disorder or PTSD, depression, and
anxiety) [5–8] and physical health conditions (e.g.,
obesity, hypertension, and chronic pain [2,9,10]. Thus,
given the increased physical and mental health co-
morbidities in veterans, treating sleep disturbance may be
an important approach because improving sleep may lead
to decreasing their health symptoms and improving their
health status, QOL, and well-being.
In recent years, sleep has received increased attention in
military personnel with PTSD, since these patients almost
always report some form of sleep disturbance [3,5]. In fact,
since sleep disturbance is so prevalent in PTSD, it is
considered a hallmark of PTSD diagnosis [11]. Two classical
PTSD symptoms, hyperarousal and re-experiencing the
traumatic event, comprise sleep difficulty and nightmares,
respectively [6]. Preliminary evidence suggests that inter-
ventions targeting sleep may be beneficial in the treatment of
PTSD [12,13].
Sleep disturbance in veterans may not always be
diagnosed or properly treated. Many veterans may not even
disclose to their primary care physicians that they suffer from
sleep disturbance since they may regard it as a commonly
occurring symptom that afflicts many people. Another reason
for lack of attention to sleep is that veterans' sleep disturbance
is embedded within a constellation of co-morbid health
symptoms, which are a higher priority in their treatment.
Under conditions of persistent sleep disturbance, treatment
usually involves use of antidepressants and benzodiazepines,
which are generally effective over the short-term, but these
have many side effects and their usage is not advisable over
the long-term [14–16].
A search for more effective alternative approaches to
pharmacotherapy for sleep management has led to the
development of a variety of cognitive and behavioral
interventions, such as cognitive behavioral therapy (CBT
[1]). Studies have shown that short-term sleep improvements
following CBT compare favorably with those achieved
using pharmacotherapy, and CBT's effects are enduring over
the longer term, even more so than pharmacological
treatments [15]. Other alternative nonpharmacotherapy
treatments include mind–body interventions such as mind-
fulness-based stress reduction (MBSR [17]) and mindful-
ness-based cognitive therapy (MBCT [18,19]). These
programs are examples of awareness training programs
(ATPs), which focus on the power of “mind training” in
regulating mental and physical states of the person [20].
These interventions have been shown to ameliorate or reduce
the severity of a wide variety of health conditions, such as
cancer, depression, anxiety, chronic pain, and hypertension
[21]. In particular, sleep disturbance has improved using
these approaches [22–29].
A recent addition to ATPs is mind–body bridging (MBB
[30–32]). MBB may have the potential to develop into a
mind–body intervention for a wide range of mental and
physical health problems. First, MBB teaches awareness
skills to help the individual calm the mind and relax the
body. Second, MBB teaches the individual to recognize and
become aware of a dysfunctional mind–body state charac-
terized by a heightened sense of self-centeredness, as
indicated by ruminative thoughts, involuntary contraction
of awareness, body tension, and impaired mental or physical
functioning. Specific ‘mind–body mapping’ exercises use a
technique of written free-association to reveal specific
thought patterns called “requirements”, i.e., expectations
about how one and the world “should be” at each moment.
Requirements that are excessively self-centered and not
fulfilled can easily lead to a dysfunctional mind–body state.
Defusing requirements through mind–body mapping will
lead to a more balanced, harmonious state. When individuals
use awareness practices and defuse requirements, their
awareness expands, making them more effective in dealing
with difficulties in their daily lives. In this way, MBB carries
awareness practices one critical step further by addressing
the underlying cause of the resistances to clarity, i.e., mental
afflictions caused by an individual's fixed idea of who she/he
is, known as the “identity system” in MBB teaching
language. The increased awareness of the identity system
may potentially account for MBB's therapeutic usefulness.
Furthermore, MBB is easy to learn and benefits accrue
rapidly. These features suggest that MBB may become a
viable clinical intervention, especially in primary care
service. (See Ref. [32] for more detailed descriptions of
MBB program content.)
Thus, a pilot randomized controlled study was conducted
to evaluate a novel mind–body awareness training program,
MBB, as a new mind–body program for helping veterans
with self-reported sleep disturbance. In view of the potential
value of MBB as a clinical intervention for managing sleep
in particular, this pilot study investigated the effects of a
short-term (two-session) sleep-focused MBB program
compared with a standard-of-care sleep hygiene (SH)
program in veterans. We evaluated whether MBB could
improve sleep symptoms as well as other co-morbid
symptoms in veterans such as PTSD, depression, and
health-related QOL. Finally, we assessed whether MBB
could increase mindfulness, which we theorize to be one of
the underlying mechanisms driving MBB in particular and
ATPs in general. We hypothesized that patients randomly
assigned to MBB would exhibit significantly greater
improvements in sleep and in other co-morbid symptoms
than patients assigned to SH, which may be in part facilitated
by increased mindfulness.
Methods
Overview
We conducted a prospective, randomized controlled trial.
Subjects were assigned to one of two interventions: a standard-
of-care SH arm and an experimental intervention MBB arm.
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Participant selection
We recruited patients (male and female US veterans,
18–70 years old) from a primary care clinic at the
Veterans Affairs Salt Lake City Health Care System
(VASLCHCS). This study was approved by the University
of Utah and VASLCHCS Institutional Review Boards. All
patients gave written informed consent and were compen-
sated for their time. Patients from VA Primary Care were
surveyed and selected in accordance with the main
objective of the study (i.e., improving management of
self-reported sleep disturbance in veterans from VA
Primary Care). Table 1 presents inclusion and exclusion
criteria used in the study.
Randomization
Patients visiting a primary care clinic at the VASLCHCS
were screened for sleep disturbance with a validated self-
report sleep questionnaire, Medical Outcomes Study Sleep
Survey (MOS-SS), using the Sleep Problems Index II
subscale [33]. Individuals who (a) gave consent for the
research team to use their MOS-SS data for study purposes,
(b) scored ≥35 on MOS-SS (see Table 2), and (c) exhibited
no severe mental health issues as determined by a physician
were deemed eligible. Prospective subjects were contacted
by phone and invited to participate in the study. Patients
giving verbal agreement were mailed a packet containing
study information, a consent form, and pre-study ques-
tionnaires, and were asked to complete all questionnaires in
advance, which on average was within 1 week of the first
intervention session. At enrollment, participants first signed
the consent form and then submitted their completed
questionnaires. Afterwards, participants were randomly
assigned in blocks of four (computer-generated random
assignment program) to one of the two interventions. Finally,
participants attended the first session.
Fig. 1 shows the flow of patients through the study. We
recruited patients between September 2008 and January
2009. We screened 421 patients with MOS-SS; 136 fell
below the 35 cutoff and were excluded. Of the 285 patients
who scored above the 35 cutoff, 222 were ineligible due to
severe mental health (72; 25.3%) or medical health issues (3;
1.1%), age (24; 8.4%), or unavailability/declined to
participate in the study (123; 43.2%). Sixty-three (22.1%)
patients agreed to participate and were randomly assigned to
one of the two interventions; 25 participants completed SH
and 33 completed MBB.
Demographics collected include age, gender, and ethnicity.
Baseline characteristics include sleep disturbance score (MOS-
SS), sleep duration, PTSD symptoms (PCL-M) total score, and
depression (CES-D) total score, as shown in Table 3.
Interventions
Sleep hygiene program
Good sleeping practices were taught to participants,
based on several guidelines that include limiting exercise,
eating, alcohol and caffeine intake before bed, using the
bed only for sleeping, and establishing a regular bedtime.
The instructor encouraged participants to follow guidelines
and to maintain a daily sleep diary for their own use to
monitor their sleep patterns. During the second session, the
instructor reiterated the sleep education guidelines and
discussed with participants various sleep issues based on
reports from their sleep diaries. The sleep education
sessions were presented by a board-certified internist at
the VASLCHCS.
Mind–body bridging program for sleep management
Each MBB session comprised several objectives that
included teaching participants basic MBB experiential tools
to improve their sleep. They learned how to identify a
possible cause of their sleep difficulties from a MBB
perspective to help them effectively deal with their sleep
problems and also help them reduce daytime stress.
Participants were encouraged to practice MBB as often as
possible throughout the day and especially at bedtime. MBB
was taught by a licensed clinical social worker who is a
certified instructor of MBB. For more details of MBB
procedures, see Ref. [32].
Outcome measures
Primary and secondary outcome measures used in the
study are presented in Table 2 [33,36–39].
Table 1
Selection criteria for patient enrollment
Selection criteria
Inclusion criteria Participants exhibited self-reported sleep disturbance
as assessed by a validated sleep questionnaire,
MOS-SS [33]; they were not required to have formal
diagnosis of either primary or secondary insomnia,
including sleep-disordered breathing, chronic
obstructive pulmonary disease, or restless leg
syndrome. Since we are broadly interested in MBB's
beneficial impact on co-morbid symptoms, patients
currently treated for depression, pain, and any general
medical conditions (e.g., hypertension, diabetes) are
not excluded. Additionally, patients on sleep
medication, antidepressants, pain medications, and
other medications for any condition that is not under
exclusion criteria were admitted into the study. Thus,
our inclusion criteria are much broader than those
used in a typical treatment study, consistent with the
main objective of the study.
Exclusion criteria Patients were excluded if they presented with
significant mental health issues, such as severe
psychosis or major depression, or were under
intensive mental health case management, as
determined by an attending physician in VA
Primary Care, or were on antipsychotic medication.
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Study procedures
The study was conducted over 3 weeks. Participants
underwent two sessions of either SH or MBB, both
specifically targeting sleep problems. Sessions ran concur-
rently over two consecutive weeks, one per week for
approximately 1 h (SH) or 1.5 h (MBB).
Participants completed all self-report questionnaires
approximately within 1 week prior to the first session (Pre)
and at least 7 days after the second session (Post).
Additionally, MOS-SS was completed at Week 1 (just
before the start of the second session).
Statistics
We employed a linear mixed-effects model with repeated
measures analysis of variance (ANOVA) with intervention
and period as two factors, using SPSS software (SPSS, Inc.,
Chicago, IL, USA). Unlike more conventional statistical
analysis methods (e.g., ANOVA), modern mixed-effects
model will never discard nor impute data [40,41]. If
significant, we then examined specific contrasts corresponding
to customized hypothesis tests comparing Pre with Post scores
within and between groups. For the sleep measure, we
additionally compared Pre to Week 1 to determine whether
sleep was affected by one intervention session. For the PTSD
symptoms, we used a mixed-effects analysis of covariance
(ANCOVA) regressing Pre scores on Post scores (Pre was
used as a covariate). Adjusted means at Post was the focus.
Results
Attendance
Sixth-three enrolled and 58 completed the study: 25 in
SH and 33 in MBB. Five dropped out after completing
pre-intervention questionnaires and participating in the first
session. Three of the five were in SH and two in MBB.
Demographics and levels of baseline self-reported symp-
toms were not different between the two groups.
While there were relatively few drop-outs (8%, five out
of 63), we included all ‘intent-to-treat’ subjects in the
analysis, using mixed-effects model. Thus, data were used
from all participants, regardless of whether they completed
the study or not, because the statistical approach used
(mixed-effects model) was able to handle missing
observations without discarding or imputing data.
Table 2
Outcome measures
Scale Description Reference
Primary outcomes
Sleep—Medical Outcomes Study-Sleep Scale (MOS-SS) This 12-item questionnaire evaluates sleep performance. We used this modified
version since it was already validated to assess sleep over the previous 7 days.
Use of other questionnaires such as the Pittsburgh Sleep Quality Inventory [34]
and Insomnia Severity Index [35]is not validated for a 1-week time frame, and
thus given the brief duration of the interventions (two sessions, 1 week apart),
we opted to use the MOS-SS for our study. Subscales derived from the
questions were (1) Sleep Disturbance, (2) Sleep Adequacy, (3) Daytime
Somnolence, (4) Snoring, (5) Waking Up Short of Breath/With a Headache, (6)
Sleep Problems Index I, (7) Sleep Problems Index II. As an assessment of
general changes in overall sleep performance, we used Sleep Problems Index II,
which comprises sleep onset latency, sleep disturbance, sleep adequacy, and
waking up with shortness of breath and/or headache. We also used the Sleep
Problems Index II for screening potential participants and used a cutoff score
≥35, which can serve as a proxy indicator of clinically diagnosed sleep
disturbance (Dr. R. Hayes, personal communication, 8/11/2009).
[33]
Quality of Life—MOS-SF-36 for Veterans
(MOS SF-36V or VR-36)
MOS-SF-36V is a well-established quality of life (QOL) scale, adapted
for veterans.
[36]
Secondary Outcomes
Depression—Center for Epidemiological Studies
Depression Scale (CES-D)
This scale is a common screening test determining an individual's
depression quotient.
[37]
Mindfulness—5-Factor Mindfulness Questionnaire
(5F-MQ)
The 5F-MQ contains five clear, interpretable facets of mindfulness based on
other mindfulness questionnaires: (1) observing, (2) describing, (3) acting with
awareness, (4) nonjudging of inner experience, and (5) nonreactivity to
inner experience.
[38]
PTSD Symptoms—PTSD Check List–Military (PCL-M) The PCL-M is a 17-item reliable self-report measure assessing PTSD severity in
people experiencing a traumatic event, specifically for the military. Total scores
above 50 are considered to reflect moderate, and above 65 severe,
PTSD symptoms.
[39]
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Descriptive statistics
As shown in Table 3, there were no differences between
MBB and SH for demographics (age and sex) and symptom
conditions at baseline. While the study comprised predom-
inantly white male veterans, female veterans and other ethnic
groups were included.
Hypothesis-driven statistical analyses
Primary outcomes
Sleep. Fig. 2 represents the distribution of change scores from
Pre to Post for theMOS-SS subscale Sleep Problems Index II.
Results are highly similar when Sleep Problems Index I was
used. The proportion of individuals who reported no
improvement or a deterioration in sleep performance from
Pre to Post was smaller in MBB (3%, one out of 33) than that
in SH (24%, six out of 25). Furthermore, the most frequent
improvement change score observed inMBBwas between 20
and 30, while that in SH was between 0 and 10.
Fig. 3 shows the means for Sleep Problems Index II
across the interventions as a function of period. The
horizontal line in the figure represents the 35 cut-off,
identifying individuals with a high probability of exhibiting
clinically relevant sleep problems. Subjects in both MBB
and SH groups reported marked improvements in sleep after
both one (Week 1) and two (Post) sessions, which appear to
be more pronounced in MBB.
Confirming these observations, the mixed-effects analysis
indicated a significant intervention by period interaction
421 patients assessed for 
eligibility by
completing MOS-SS
136 excluded:
scored below 35 cutoff in MOS-SS 
(sleep disturbance exclusion)
285 patients scored above 35 
cutoff  in MOS-SS (sleep 
disturbance inclusion)
222 excluded due to:  
72 - severe mental health issues
123 - unavailability/not returning calls 
24 - age 
3 - medical issues
63 participants enrolled and 
randomized 
28 participants allocated to 
SH; 25 completed
3 dropped out during study -
non-compliance unknown
35 participants allocated to 
MBB; 33 completed
2 dropped out during study -
non-compliance unknown
Fig. 1. Study flow diagram.
Table 3
Demographics of participants in each of the interventions in the study
SH MBB
Age 49.9 (10.3) ⁎ 53.8 (10.4)
Males 27 33
Females 1 2
Enrolled 28 35
Completed 25 33
Baseline characteristics
Sleep Problems Index II score 56.4 (16.6) 61.4 (14.1)
Total sleep time (h) 5.5 (1.6) 5.7 (1.7)
Depression rating (CES-D) 24.0 (11.1) 24.5 (12.2)
PTSD Symptoms (PCL-M) 43.5 (18.0) 42.2 (16.6)
⁎ Standard deviation in parentheses.
339Y. Nakamura et al. / Journal of Psychosomatic Research 70 (2011) 335–345
effect (P=.028) with a corresponding effect size (ES) of .74.
Specific (a priori) contrasts showed that the magnitude of
improvement in sleep for MBB was significantly greater
than that for SH at both Week 1 [MBB (21.0, ES=1.3) vs. SH
(12.8, ES=.73); P=.047] and at Post [MBB (28.0, ES=1.89)
vs. SH (14.8, ES=.71); P=.012] (Fig. 3).
Table 4 presents the means for each individual MOS-SS
subscale. Mixed-effects analysis indicated a significant
intervention by period interaction effect for the sleep
disturbance subscale (P=.006). Specific contrasts showed
that the mean sleep disturbance score in MBB was
significantly lower than that in SH at Week 1 (P=.021) and
Post (P=.002). For within-groups analyses, mean sleep
disturbance scores declined significantly at Week 1 (MBB,
Pb.001; SH Pb.01) and Post (MBB, Pb.001; SH Pb.001).
No other subscale exhibited significant intervention by period
interaction effects. Thus, improvements in the sleep distur-
bance subscale may account for the results obtained based on
the Sleep Problems Index II, in terms of the effects of both
interventions to facilitate improvements in sleep symptoms.
Quality of life. Table 5 presents the results obtained for all
subscales in SF-36V. Observed changes in subscale and
overall QOL indicators were in the expected direction for
MBB participants compared to those in SH participants.
However, mixed-effects analysis revealed that the interven-
tion by period interaction was not significant for any one of
these subscales.
Secondary outcomes
PTSD Symptoms. Fig. 4A indicates mean PCL-M scores
across the interventions as a function of period. The MBB
group showed a greater decline in scores than did the SH
group from Pre and Post.
Confirming this observation, the two-factor mixed-effects
model analysis revealed a significant intervention by period
interaction effect (P=.029, ES=.32), indicating that the
severity of PTSD symptoms based on PCL-M scores at
Post was significantly lessened in MBB (change score=8.1,
ES=.54) than in SH (change score=2.6, ES=.13).
Since mean PCL-M Pre scores in both groups were below
the 50 cutoff indicative of more severe PTSD symptoms, we
examined whether the two interventions differed for those
participants whose PCL-M score was greater than 50. Fig.
4B shows that PTSD symptoms were reduced at Post to a
greater extent in MBB (n=11) than in SH (n=9), which
replicates the same pattern of change observed across all
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Fig. 2. Histogram distribution for interventions depicting the magnitude of
change in sleep symptoms from Pre- to Post-interventions, based on MOS-
SS Sleep Problems Index II. A fewer subjects in MBB showed no
improvement or worsening of sleep symptoms (3%, one out of 33) than in
SH (24%, six out of 25). Note that two of the six SH individuals had change
scores of 0, included in the third bin; positive values=sleep symptom
improvement, negative values=worsening of sleep symptoms.
Fig. 3. Effects of sleep interventions on sleep performance. Means and 95%
CIs of MOS-SS Sleep Problems Index II scores for MBB and SH at Week 1
(just prior to the start of the second session) and Post. Mixed-effects analysis
of sleep scores indicated a significant overall intervention by period
interaction effect (P=.028), in which MBB led to greater improvements in
sleep performance than did SH at both Week 1 (P=.047) and Post (P=.012).
In addition, at Post, mean sleep score in MBB declined below the 35 cutoff,
indicating that the majority of MBB subjects reported sleep improvements
reaching subclinical levels.
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subjects (Fig. 4A). Since statistical analysis of this
subsample was not appropriate, we analyzed the entire data
set using a mixed-effects ANCOVA with Pre score as a
covariate and Post score as a dependent variable.
Fig. 5 presents scatter plots of Post plotted against Pre
PCL-M scores. Each line corresponds to the regression of the
Post measure on the Pre for SH and MBB, respectively.
Since there is a significant interaction (P=.011) between
intervention and the covariate (Pre PCL-M score) revealing
nonhomogeneity of regression, this shows that MBB and SH
slopes are not parallel, indicating that one cannot interpret
the intervention effect as a test of adjusted means. (This
nonhomogeneity of regression can be translated as a
relational outcome of the intervention on the PCL-M scores
from Pre to Post [42,43].) Instead, we employed the
Johnson–Neyman [44] procedure, examining adjusted
differences for various values of Pre (covariate) scores.
Mean Post scores between the two interventions were
significantly different (P=.049), conditional on Pre scores
greater than or equal to 38.9, as indicated by the shaded
region of the graph in Fig. 5. At the clinically meaningful
value of 50 in Pre PCL-M total score, the adjusted mean Post
PCL-M score for MBB was significantly lower (P=.001)
than that for SH group. Thus, MBB did have a positive
impact in reducing Post scores, relative to SH, in individuals
with Pre PCL-M scores of 50 and greater. This suggests that
MBB was effective for reducing self-reported PTSD
symptoms in veterans whose initial PCL-M scores were
above 50, supporting potential impact of MBB on self-
reported PTSD symptoms.
Mindfulness. Fig. 6 shows 5F-MQ means for overall levels
of mindfulness across the two interventions as a function of
period. A two-factor mixed-effects model analysis revealed a
significant intervention by period interaction effect (P=.052,
ES=.46). Thus, MBB showed a greater increase from Pre to
Post in mindfulness scores (9.3, ES=.46) than did SH (−0.16,
ES=−.0.01).
Depression. Depression symptoms, as reflected in CES-D
scores from Pre to Post, decreased in both interventions.
While the decrease was greater for MBB (5.8) than for SH
(2.0), the mixed-effects model analysis indicated that the
intervention by period interaction effect was not significant.
Table 4
Means and standard deviations of MOS-SS subscale scores for comparisons between SH and MBB
MOS-SS Subscales
SH MBB
Pre Week 1 Post Pre Week 1 Post
Sleep Adequacy 33.21 (21.44) ⁎ 42.80 (23.90) 45.60 (27.85) 29.43 (19.39) 48.24 (23.67) 54.24 (22.50)
Sleep Disturbance 56.35 (23.11) 43.40 # (22.97) 41.58 + (27.69) 62.68 (16.69) 37.79 # (19.83) 31.97+ (19.04)
Somnolence 55.95 (20.56) 38.13 (24.69) 34.93 (28.11) 53.90 (24.11) 37.45 (24.51) 30.91 (23.14)
Snoring 50.71 (36.71) 40.00 (35.39) 36.80 (33.51) 60.00 (34.82) 45.81 (35.48) 44.67 (38.12)
Wake Up Short of Breath/With a Headache 27.14 (28.40) 14.40 (24.85) 18.40 (28.82) 38.29 (30.82) 28.24 (31.57) 17.58 (21.07)
Sleep Problems Index I 54.52 (16.11) 42.53 # (18.74) 41.60 + (24.70) 60.29 (15.39) 40.78 # (19.76) 32.93+ (16.72)
⁎ Standard deviation in parentheses.
# For Week 1–Pre, Pb.01.
+ For Post–Pre, Pb.01.
Table 5
Means and standard deviations of (1) SF-36V subscales and total scores and (2) CES-D total scores, for comparisons between SH and MBB
SH MBB
Pre Post Pre Post
(1) SF-36V
Physical functioning 65.42 (23.57) ⁎ 65.20 (21.38) 61.00 (26.17) 65.48 (26.26)
Role limitations due to physical health 52.68 (29.83) 59.50 (28.36) 56.85 (26.78) 70.08 (22.08)
Role limitations due to emotional problems 57.44 (28.09) 64.33 (29.22) 62.38 (42.02) 72.98 (24.65)
Energy/fatigue 42.50 (13.30) 44.40 (16.48) 42.14 (15.59) 46.21 (14.09)
Emotional well-being 38.71 (9.62) 35.84 (14.81) 39.20 (11.67) 39.76 (13.53)
Social functioning 50.45 (26.02) 59.00 (31.15) 57.50 (28.79) 65.15 (21.60)
Pain 49.29 (27.59) 52.40 (27.09) 50.50 (24.73) 59.39 (19.05)
General health 53.35 (9.18) 51.30 (7.68) 55.11 (10.83) 51.52 (10.21)
One year physical health 40.18 (25.77) 45.00 (29.76) 44.29 (24.32) 49.24 (26.13)
One year emotional problems 38.39 (24.98) 45.00 (25.00) 42.14 (19.90) 53.79 (26.61)
Total SF-36V score 488.40 (138.66) 521.97 (162.09) 511.10 (127.90) 573.60 (115.95)
(2) CES-D
Total CES-D score 23.96 (11.12) 22.00 (14.37) 24.51 (12.21) 18.73 (11.67)
⁎ Standard deviation in parentheses.
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Table 5 at the bottom presents means and standard deviations
of CES-D for both groups.
Discussion
Sleep-focused MBB in two sessions greatly reduced
patient-reported sleep disturbance and PTSD symptoms, and
increased higher overall levels of mindfulness than those
observed in the standard-of-care SH intervention. These
outcomes are notable, since significant reductions in self-
reported PTSD symptoms were observed when MBB was
specifically tailored for improving sleep without explicitly
targeting PTSD. Similarly, mindfulness increased even
though MBB involved no specific formal practice of
mindfulness meditation. These results provide preliminary
support for the possibility that sleep-focused MBB is a
potentially beneficial intervention for individuals with sleep
disturbance and other co-morbid symptoms (e.g., PTSD).
In contrast, there were no reliable improvements in either
depression symptoms or in quality-of-life indices such as
pain, overall physical and mental health, or energy and
vitality, in either intervention. It is possible that these
indicators may be more resistant to short-term changes, and
more beneficial outcomes may require longer intervention
durations and increased number of intervention sessions. A
future study should explore the issue of the minimum
number of MBB sessions required to optimally produce
changes in those indicators.
Our objective in this study was to assess the potential
value of MBB in improving self-reported sleep and
A
B
Fig. 4. Effects of sleep interventions on PTSD symptoms. (A) Means and
95% CIs of PCL-M total scores across interventions as a function of period.
Mixed-effects analysis of PCL-M total scores showed a significant
intervention by period interaction effect (P=.029). PTSD symptom scores
were significantly lower for MBB than for SH at Post. (B) Mean (95% CI)
PCL-M total scores between interventions for participants with Pre scores
greater than 50. At Post, MBB participants (n=11) showed reductions in
PTSD symptoms, while SH participants did not (n=9).
Fig. 5. Scatter plots with regression lines for Post vs. Pre PCL-M scores for
each intervention. Slopes across the two groups are significantly different
from each other (P=.011; slopes: SH, r=0.99; MBB, r=0.59), which
required that the data should be analyzed by the Johnson–Neyman [44]
procedure. PCL-M Post scores declined significantly in MBB than in SH for
Pre scores 38.9 and greater (P=.049). Shaded region corresponds to values
of Post PCL-M scores in which the two groups were significantly different
(see text for more details).
Fig. 6. Effects of sleep interventions on mindfulness measures. Means and
95% CIs of 5F-MQ scores for mindfulness across interventions as a function
of period. Mixed-effects analysis revealed a significant intervention by
period interaction effect (P=.052). Mindfulness increased significantly from
Pre to Post in MBB but not in SH.
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comorbid symptoms in a cross section of veterans visiting
the VASLCHCS Primary Care clinics, without specifying
what specific type of sleep problems they may have been
experiencing. At post-assessment, mean self-reported sleep
scores from MBB declined below the cutoff point indicative
of sleep problems (greater than 35). The data are consistent
with the hypothesis that MBB would improve self-reported
sleep quality in veterans, encouraging a future clinical study
of MBB with patients who may suffer from a specific sleep
condition such as primary or secondary insomnia. However,
at this point, we cannot claim that MBB effectively treated
specific sleep disorders as assessed by clinical evaluation,
including insomnia, sleep apnea, restless leg syndrome, or
sleep-disordered breathing.
Improving sleep in individuals with PTSD using an
adjuvant sleep intervention has begun to attract attention
because of the known links between sleep disturbance and
psychological health [7,45]. However, unlike other studies
that examined whether a sleep intervention could improve
PTSD symptoms as part of a general PTSD treatment
regimen [12], in our study, we opted to target sleep
exclusively, given the possibility that improved sleep can
influence other health conditions, and we hypothesized that
other co-morbid symptoms might be altered by a mind–body
intervention selectively targeting sleep. For those patients
with moderate to severe self-reported PTSD symptoms at
pre-assessment, their post PCL-M scores in MBB dropped
below the standard cutoff point of 50, a clinically meaningful
severity level requiring more extensive clinical assessment.
While the study did not confirm that any of our subjects had
PTSD diagnosis, the data provide promising initial evidence
that MBB positively altered self-reported PTSD symptoms
in veterans. Our study showed that primary care patients self-
reporting moderate to severe PTSD symptoms may be
responsive to a mind–body intervention focusing on sleep
even when it is not specifically targeting PTSD.
These data are consistent with findings obtained using
other intervention approaches showing efficacy in treating
sleep disturbance. CBT was effective over a short-term
period (one to four sessions) [46,47] as was observed for
MBB in two sessions in the present study. Conversely,
MBSR-type therapies may require longer intervention
durations (i.e., six sessions or longer) to exert their effects
(for a more extensive discussion on this issue, see Ref. [48]).
Nonetheless, these findings are generally consistent with
another study reported in the literature demonstrating the
effectiveness of a brief behavioral intervention targeting
insomnia and post-traumatic nightmares [12].
The effectiveness of mindfulness practice facilitating
health and well-being, including sleep, has been reported in
numerous studies utilizing several interventions [21–29].
We postulated that increased mindfulness or awareness
might have in part led to improvements in sleep and
reductions in self-reported PTSD symptoms. Changes in
mindfulness in this study are notable, especially given (1) the
brief nature of the intervention (two sessions, once per
week), and (2) unlike other mindfulness-based interventions
(MBSR, MBCT) in which mindfulness meditation practices
are core interventional components and are intrinsic to their
effectiveness, MBB curriculum does not include formal
meditation practice per se. This raises an interesting question
as to how MBB exerted its effects, and future studies should
examine this question empirically.
Our study population comprised a diverse group of
veterans currently treated by VA physicians. We strategi-
cally selected primary care clinics at the VASLCHCS to
recruit these subjects since (1) a high proportion of veterans
suffer from sleep disturbance that is often unreported and
untreated, and (b) in veterans, sleep disturbance is
commonly associated with numerous physical and mental
health co-morbidities, especially PTSD and depression
[5,6]. Since this study assessed the efficacy of MBB as a
novel sleep management intervention in veterans, we did
not restrict our selection criteria to a specific sleep problem.
The more inclusive selection criteria in this study as well as
the screening and testing of veterans over the course of 6
months may enhance the generalizability (i.e., external
validity) of these findings to other veterans, since those
enrolled in the study may be representative of the larger
veteran population seen at primary care clinics within the
VA Health Care System. The results of our study have
important implications for targeting sleep in veterans, with
potential additional benefits to co-morbid health symptoms.
Nonetheless, we are keenly aware of limitations of this
pilot study that we plan to address in future clinical trials
testing MBB. Limitations include the following: no clinical
evaluation of participants by clinicians (veterans who
participated in the study, however, had been seeing their
primary care physicians for any medical problems), no
explicit assessment of intervention fidelity, a small differ-
ence of approximately 30 min in the duration of the two
intervention programs, assessment of intervention efficacy
solely based on self-report questionnaires, no measures of
daily changes in sleep patterns based on sleep diary data, and
no follow-up assessment. While these limitations do not
entirely detract from the results obtained, future studies for
testing MBB should implement stronger measures to
improve these shortcomings.
The present findings suggest that MBB can serve as a
cost-effective nonpharmacological intervention program for
sleep management in primary care settings in veterans with
self-reported sleep disturbance. Furthermore, because MBB
is easy to learn and cumulative benefits are obtained in
only a few sessions, MBB can develop into an ideal
vehicle for managing multiple co-morbid symptoms and
may specifically serve as a front-loaded program for
addressing sleep problems among VA patients with
psychological co-morbid conditions (e.g., PTSD). Future
studies might investigate the degree to which veterans may
reduce the need for and use of sleep medications and may
include an assessment of well-being in veterans enhanced
by MBB.
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